High-quality RCTs show cannabidiol reduces monthly seizure frequency by about 20% compared to placebo in children with drug-resistant epilepsy, though it does not significantly increase seizure freedom rates.
Parents of children with epilepsy, people interested in CBD medical evidence, and anyone following cannabis-based medicine.
CBD reduced monthly seizures by 19.8% vs placebo in drug-resistant pediatric epilepsy
What the researchers found
CBD reduced median monthly seizure frequency by 19.8% vs placebo (95% CI: -27.0% to -12.6%) and increased the proportion achieving 50%+ seizure reduction (RR = 1.76). However, seizure freedom was not significantly different. Diarrhea was significantly more common with CBD (RR = 2.25).
Why it matters
This provides the most rigorous assessment of CBD for pediatric epilepsy at the time of publication. The moderate-certainty evidence supports its use for drug-resistant cases, while clearly noting that results apply specifically to pharmaceutical-grade CBD, not all cannabis products.
The numbers in context
4 RCTs + 19 non-randomized studies. Seizure frequency reduction: -19.8% (95% CI: -27.0% to -12.6%). 50%+ seizure reduction: RR 1.76 (95% CI: 1.07-2.88). Diarrhea: RR 2.25 (95% CI: 1.38-3.68). No significant difference in seizure freedom, quality of life, or sleep.
How the study worked
Living systematic review with meta-analysis of 4 RCTs and 19 non-randomized studies. Searched MEDLINE, Embase, PsycINFO, Cochrane Library, and gray literature. Risk of bias assessed per study; GRADE used for quality of evidence per outcome.
What this study cannot tell us
All non-randomized studies were at high risk of bias. Evidence is primarily limited to pharmaceutical-grade CBD. Quality of life and sleep outcomes showed no significant improvement. Short follow-up periods in most studies.
How to read the evidence
Strong: systematic review with meta-analysis including 4 low-risk-of-bias RCTs and GRADE quality assessment.
When this study was published
Published in 2019.
The bigger picture
This review arrived as CBD products were flooding consumer markets with epilepsy claims. The evidence specifically supports pharmaceutical-grade cannabidiol for specific severe epilepsies, not broad use of unregulated CBD products for seizure disorders.
Questions still open
- Would longer treatment periods show improvements in quality of life and sleep? Does CBD work for epilepsy types beyond Dravet and Lennox-Gastaut syndromes? How much of the seizure benefit is attributable to CBD's interaction with clobazam rather than direct effects?
Common questions
Does CBD help children with epilepsy?
Can any CBD product be used for epilepsy?
Read the original research
Cannabis-based products for pediatric epilepsy: A systematic review.
Epilepsia, 60(1), 6-19
Citation
Elliott, Jesse; DeJean, Deirdre; Clifford, Tammy; Coyle, Doug; Potter, Beth K; Skidmore, Becky; Alexander, Christine; Repetski, Alexander E; Shukla, Vijay; McCoy, Bláthnaid; Wells, George A. (2019). Cannabis-based products for pediatric epilepsy: A systematic review.. Epilepsia, 60(1), 6-19. https://doi.org/10.1111/epi.14608
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk